POSTOPERATIVE CARCINOEMBRYONIC ANTIGEN LEVELS AND ASSOCIATED FACTORS IN PATIENTS WITH EARLY-STAGE COLORECTAL CANCER
Main Article Content
Abstract
Background: Carcinoembryonic antigen (CEA) is widely used for monitoring treatment response in colorectal cancer. Recent evidence suggests that postoperative CEA levels may also have prognostic value in patients with early-stage disease. Objectives: To investigate postoperative Carcinoembryonic antigen levels and associated factors in patients with early-stage colorectal cancer at Can Tho University of Medicine and Pharmacy Hospital from May 2024 to May 2025. Materials and methods: A descriptive case-series study was conducted on 91 patients diagnosed with earlystage colorectal cancer who underwent curative surgery at Can Tho University of Medicine and Pharmacy Hospital. Results: The postoperative Carcinoembryonic antigen level was 5.6 ± 13.46 ng/mL with 14.3% of patients having values above the normal range. Disease stage was found to influence postoperative Carcinoembryonic antigen levels in patients with early-stage colorectal cancer. Conclusions: Most patients had postoperative CEA levels within the normal range. Disease stage was significantly associated with postoperative CEA levels in patients with early-stage colorectal cancer.
Keywords
Colorectal cancer, Carcinoembryonic antigen
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
2. Wang Weicheng, Wang Rui, Han Xiao, Zhang Wei, Zhu Lijun, et al. Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer. Medicine (Baltimore). 2024. 103(14), e37693, 10.1097/MD.0000000000037693.
3. Kang SI. Carcinoembryonic Antigen, the Most Accessible Test for Predicting Prognosis of Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Annals of Coloproctology. 2021. 37(2), 70-71, https://doi.org/10.3393/ac.2021.00493.0070.
4. Phạm Thị Phương, Trịnh Lê Huy. Đánh giá nồng độ CEA trước và sau điều trị ung thư đại trực tràng. Tạp chí Y - Dược học quân sự. 2021. 2, 76 – 82.
5. Gizem Kececi Ozgur, Ahmet Kayahan Tekneci, Edward Hassan Bakali, Tevfik Ilker Akcam, Ayse Gul Ergonul et al. The Importance of tumor markers in patients undergoing resection for lung metastasis of colorectal carcinoma. The Clinical Respiratory Journal. 2023. 17(5), 429 - 438, https://doi.org/10.1111/crj.13611.
6. Kim HR, Joo JI, Lim SW, Oh BY. Prognostic value of carcinoembryonic antigen levels before and after curative surgery in colon cancer patients. Annals of Surgical Treatment and Research. 2021. 100(1), 33-4, https://doi.org/10.4174/astr.2021.100.1.33.
7. Kim HG, Lee JL, Park IJ, Kim CW, Yoon YS, et al. Prognostic significance of serum carcinoembryonic antigen categorized by its level after curative resection in patients with colon cancer. Annals of Surgical Treatment and Research. 2021. 100(1), 33-41.
8. Zhenhui Li, Dafu Zhang, Xiaolin Pang, Shan Yan, Ming Lei, et al. Association Between Serum Carcinoembryonic Antigen Levels at Different Perioperative Time Points and Colorectal Cancer Outcomes. Front Oncol. 2021. 11, 722883, https://doi.org/10.3389/fonc.2021.722883.
9. Liu F, Jiang S, Cui J, Wu Y, Chen S, Yu Z. Prognostic value of the postoperative carcinoembryonic antigen level in colorectal cancer: A meta-analysis. World Journal of Surgery. 2024. 48, 2359-2375, https://doi.org/10.1002/wjs.12349.
10. Chih-Sheng Huang, Chin-Yau Chen, Li-Kuo Huang, Wei-Shu Wang, Shung-Haur Yang. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke. PloS One. 2020. 15(6), e0233687, https://doi.org/10.1371/journal.pone.0233687.
11. Du Fenqi, Liu Yupeng, Zhang Qiuju, Yuan Chao, Song Wenjie, et al. Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA. Frontiers in Oncology. 2021. 11, 758509, https://doi.org/10.3389/fonc.2021.758509.